electroCore (ECOR) Cash from Operations (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | electroCore | 92,394.96 | -8.79 Mn | 8.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -120.26% |
| Dec 31, 2025 | 989.57% |
| Sep 30, 2025 | -167.90% |
| Jun 30, 2025 | 85.69% |
| Mar 31, 2025 | -134.58% |
| Dec 31, 2024 | 226.02% |
| Sep 30, 2024 | -687.82% |
| Jun 30, 2024 | -34.62% |
| Mar 31, 2024 | -18.75% |
| Dec 31, 2023 | 39.13% |
| Sep 30, 2023 | -84.73% |
| Jun 30, 2023 | 357.00% |
| Mar 31, 2023 | -45.99% |
| Dec 31, 2022 | 12.87% |
| Sep 30, 2022 | -42.02% |
| Jun 30, 2022 | 32.13% |
| Mar 31, 2022 | -9.78% |
| Dec 31, 2021 | -26.31% |
| Sep 30, 2021 | 65.62% |
| Jun 30, 2021 | -338.71% |
| Mar 31, 2021 | -88.52% |
| Dec 31, 2020 | 1,023.76% |
| Sep 30, 2020 | 1.54% |
| Jun 30, 2020 | 52.64% |
| Mar 31, 2020 | 6.83% |
| Dec 31, 2019 | -10.63% |
| Sep 30, 2019 | 27.21% |
| Jun 30, 2019 | 31.00% |
| Mar 31, 2019 | -34.67% |
| Dec 31, 2018 | 12.79% |
| Sep 30, 2018 | -23.66% |
| Jun 30, 2018 | -16.68% |
| Mar 31, 2018 | -20.59% |
| Dec 31, 2017 | -21.89% |